Otros idiomas Evogene Ltd. Nasdaq

Acciones

EVGN

IL0011050551

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:00 07/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,6949 ^USD	+2,19 %		-6,72 %	-17,27 %

23/05	Evogene Ltd. Proporciona orientación de ingresos para el año 2024	CI
23/05	Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Evogene : Immediate Report of Meeting	06/06
Evogene : Corporate Presentation	29/05
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma - Evogene	24/05
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma	23/05
Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	23/05
Evogene Reports First Quarter 2024 Financial Results - Evogene	23/05
Evogene Ltd. Provides Revenue Guidance for the Year 2024	23/05
Evogene : Q1 2024 Consolidated Financial Statements	23/05
Evogene: Q1 Earnings Snapshot	23/05
Evogene Reports First Quarter 2024 Financial Results	23/05
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds - Evogene	22/05
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds	21/05
Evogene Schedules First Quarter 2024 Financial Results Release - Evogene	09/05
Schedules First Quarter 2024 Financial Results Release on May 23, 2024,conference call to discuss the results at 9:00 AM EST	09/05
Evogene : 2024 Annual General Meeting of Shareholders	02/05
Evogene : Immediate Report of Meeting	30/04
Evogene : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 6, 2024 - Form 6-K	30/04
Biomica to Present at the American Society of Clinical Oncology 2024 Annual Meeting	17/04
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - Evogene	17/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Evogene Ltd. Nasdaq

Acciones

EVGN

IL0011050551

Otros idiomas

Filtros